Stalicla is a biotech company developing a first in class precision medicine platform to accelerate drug development for patients with neurodevelopmental disorders (ndds). First focus of development has been autism spectrum disorder (asd). Today, patients diagnosed with asd account for 1-1.5% of the world population and the condition remains a high unmet medical need.
Conecta con tecnoempleo.com